ABOUT DR.
UNKNOWN FACTS KANURY
RAO
Dr. Kanury Rao is also known as Kanury Venkata Subba Rao is an immunologist and scientist from India who is widely known for his continuous research in the field of immunology. He is actively working. He was born in India on September 27, 1958. Since he was a little boy, he has always had a fascination with science. He had a reputation for being a good student and had been an expert in biology since he was young. He was a member of the Department of Science and Technology’s Science and Engineering Research Board. From 2004 to 2008, Dr. Rao served as the Indian Immunology Society’s president. He oversaw the Translational Health Science and Technology Institute (THSTI) in Faridabad’s Drug Discovery Research Center (DDRC). He is renowned for his research on cell signalling, peptide synthesis, and the creation of synthetic peptide vaccines.
The immunologist had the chance to operate under Miles R. Chedekel’s direction for two years. Kanury Rao has stated that at this time, his expertise of the field improved. The immunologist afterwards wanted to understand more about immunology in- depth. As a result, he started working under Fred C’s supervision. An assistant researcher was needed at the University of California. Mr. Rao returned to India in 1988 following his research in California. He distinguished his profession shortly after returning by joining the International Centre for Genetic Engineering and Biotechnology and serving as a member of that organisation until 1991. He later started working till 1994 as a research assistant. Kanury Rao began serving as the Immunology Group’s Group Leader in 1994.
Career
PredOmix Technologies, a healthcare technology firm based in Gurgaon, has introduced a new blood test that can identify certain cancers in women at an early stage. One of the directors at PredOmix Technologies is Dr. Kanury Rao. This could significantly improve disease diagnosis, saving millions of lives. Cancer deaths account for over 70% of all fatalities and are frequently due to later-stage detection. The test’s creators want to lower the nation’s rate of advanced malignancies.
This blood test, which uses distinctive biochemical patterns to detect early stages of cancers particular to women, has an accuracy rate of more than 98 percent. Due to a lack of reliable diagnostic methods, cancers are difficult to identify and frequently go untreated until they have progressed to a serious stage. The main cause of India’s low cancer survival rates is due to this. Current screening procedures rely on optical, imaging, and other biomarker-based analysis, which means the tumor, must enlarge sufficiently before it can be recognized with accuracy. Only a small percentage of patients get an early diagnosis. Patients who receive a late diagnosis must fight their cancer for a long time.
Rao About New Blood Test
Recent Achivements of Dr Kanury
An accomplished Indian physicist named Dr. Kanury Rao recently entered the literary world and published a book titled At The Doorsteps of Moksha. The book is a humorous attempt to clarify the differences between two opposing viewpoints. It was written by Dr. Kanury Rao and uses a made-up scenario to eloquently define the term Moksha. At The Doorstep To Moksha focuses excellently on human civilization and its emotional behavior holding onto the past and standing by itself.
About the book At The Doorstep To Moksha, by Dr. Kanury Rao
This new blood test from PredOmix may simultaneously detect four distinct cancers: ovarian, endometrial, breast, and cervical. Early cancer identification is what saves lives, according to Dr. Kanury Rao, Chief Scientific Officer of PredOmix. According to Dr. Kanury Rao, we have created this test for early detection in order to diagnose cancer earlier, start treatment earlier, avoid some long-term issues, and help women live longer.
About technology for early-stage cancer detection
The storyline of At The Doorstep to Moksha concentrates on the protagonist, Gururaj, who dies in vain and then miraculously emerges from his body to discover himself. As the plot revolves around the actual concept of Moksha, the book’s structure is very natural. The journey that this book puts its readers on is spiritual. Being an independent reader, the culture and mindset of human civilization has always piqued my interest, Dr. Kanury Rao explained. The main worry of our day is that humanity appears to be moving backwards by isolating itself into little geographic “ghettos,” each of which is based on its own particular, localized concepts of identity. The book is merely an effort to present the viewpoint of those who are close to liberty.
An amazing new method has been created by renowned Indian scientist Dr. Kanury Rao and his team to identify early-stage malignancies in women. Currently, the test can identify ovarian, breast, uterine, and cervical cancers in their early stages. Using a method known as mass spectrometry, the technology created by Dr. Kanury Rao and his team examines tiny chemicals, or metabolites, found in the blood of patients. The data is then examined by an artificial intelligence computer to find metabolite patterns that indicate the malignancy. The team has filed a global patent and estimates the accuracy of this technology at roughly 98%.
Both in industrialized and emerging nations, cancer is rapidly replacing heart disease as the leading cause of death, and incidence rates are also raising quickly. According to Dr. Kanury Rao, the majority of cancer cases result in a diagnosis that happens due of latency Because of this, the prognosis is already dire when treatment begins. He continues, “Early detection is crucial to lowering cancer-related fatalities. Because the cancer has not considerably advanced at this point and may still be treatable.
Dr. Kanury Rao further underlines how this technology has a broad application and has room for growth. The scope of Stage021 has recently been expanded to include a total of 12 cancers in women. Lung, thyroid, kidney, leukemia, lymphoma, colorectal, melanoma, and pancreatic cancers are among the other cancers that can now be diagnosed in addition to breast, uterine, cervical, and ovarian cancers. At this time, they have a 96% accuracy rate. Dr. Kanury Venkata Subba Rao believes that the technology he and his team have created is a breakthrough because many of these malignancies are extremely difficult to diagnose.